Trace amounts of copper induce neurotoxicity in the cholesterol-fed mice through apoptosis

FEBS Letters

Volumn 580, Issue 28-29, 2006, Pages 6730-6740

  Lu, Jun ^a,b   Zheng, Yuan lin ^b   Wu, Dong mei ^b   Sun, Dong xu ^b   Shan, Qun ^b   Fan, Shao hua ^b  

^a Institute of Molecular Medicine   (China)

^b JIANGSU NORMAL UNIVERSITY   (China)

Author keywords

Apoptosis; Cholesterol; Copper; Neurotoxicity

Indexed keywords

AMYLOID PRECURSOR PROTEIN; CASPASE 3; CHOLESTEROL; COPPER; MALONALDEHYDE; MESSENGER RNA; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN; CHOLESTEROL DIET; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; MALE; MOUSE; NEUROTOXICITY; NICK END LABELING; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; APOPTOSIS; CASPASE 3; CEREBRAL CORTEX; CHOLESTEROL; COPPER; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; HIPPOCAMPUS; LEARNING DISORDERS; MALE; MALONDIALDEHYDE; MAZE LEARNING; MEMORY DISORDERS; MICE; NEURONS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SUPEROXIDE DISMUTASE;

EID: 36148943585     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2006.10.072     Document Type: Article

References (30)

1. Camakaris J., Voskoboinik I., and Mercer J.F. Molecular mechanisms of copper homeostasis. Biochem. Biophys. Res. Commun. 261 (1999) 225-232
2. Kroneck P.H.M., Antholini W.A., Riester J., and Zumft W.G. The cupric site in nitrous oxide reductase contains a mixed-valence [Cu(II), Cu(I)] binuclear center: a multifrequency electron paramagnetic resonance investigation. FEBS Lett. 242 (1989) 70-74
3. Multhaup G., Schlicksupp A., Hesse L., Beher D., Ruppert T., Masters C.L., and Beyreuther K. The amyloid precursor protein of Alzheimer's disease in the reduction of copper(II) to copper(I). Science 271 (1996) 1406-1409
4. Barnham K.J., McKinstry W.J., Multhaup G., Galatis D., Morton C.J., Curtain C.C., Williamson N.A., White A.R., Hinds M.G., Norton R.S., Beyreuther K., Masters C.L., Parker M.W., and Cappai R. Structure of the Alzheimer's disease amyloid precursor protein copper binding domain. A regulator of neuronal copper homeostasis. J. Biol. Chem. 278 (2003) 17401-17407
5. Atwood C.S., Moir R.D., Huang X., Scarpa R.C., Bacarra N.M., Romano D.M., Hartshorn M.A., Tanzi R.E., and Bush A.I. Dramatic aggregation of Alzheimer Aβ by Cu(II) is induced by conditions representing physiological acidosis. J. Biol. Chem. 273 (1998) 12817-12826
6. Atwood C.S., Scarpa R.C., Huang X., Moir R.D., Jones W.D., Fairlie D.P., Tanzi R.E., and Bush A.I. Characterization of copper interactions with Alzheimer Aβ peptides: identification of an attomolar affinity copper binding site on Aβ1-42. J. Neurochem. 75 (2000) 1219-1233
7. Huang X., Moir R.D., Tanzi R.E., Bush A.I., and Rogers J.T. Redox-active metals, oxidative stress, and Alzheimer's disease pathology. Ann. NY Acad. Sci. 1012 (2004) 153-163
8. Atwood C.S., Obrenovich M.E., Liu T., Chan H., Perry G., Smith M.A., and Martins R.N. Amyloid-beta: a chameleon walking in two worlds: a review of the trophic and toxic properties of amyloid-beta. Brain Res. Rev. 43 (2003) 1-16
9. Kontush A., Berndt C., Weber W., Akopyan V., Arlt S., Schippling S., and Beisiegel U. Amyloid-beta is an antioxidant for lipoproteins in cerebrospinal fluid and plasma. Free Radic. Biol. Med. 30 (2001) 119-128
10. Goritz C., Mauch D.H., and Pfrieger F.W. Multiple mechanisms mediate cholesterol-induced synaptogenesis in a CNS neuron. Mol. Cell. Neurosci. 29 (2005) 190-201
11. Dietschy J.M., and Turley S.D. Cholesterol metabolism in the brain. Curr. Opin. Lipidol. 12 (2001) 105-112
12. Oksman M., Iivonen H., Hogyes E., Amtul Z., Penke B., Leenders I., Broersen L., Lütjohann D., Hartmann T., and Tanila H. Impact of different saturated fatty acid, polyunsaturated fatty acid and cholesterol containing diets on beta-amyloid accumulation in APP/PS1 transgenic mice. Neurobiol. Dis. 23 (2006) 563-572
13. Schneider A., Schulz-Schaeffer W., Hartmann T., Schulz J.B., and Simons M. Cholesterol depletion reduces aggregation of amyloid-beta peptide in hippocampal neurons. Neurobiol. Dis. 23 (2006) 573-577
14. Rao K.S.J., Hegde M.L., Anitha S., Musicco M., Zucca F.A., Turro N.J., and Zecca L. Amyloid beta and neuromelanin - Toxic or protective molecules? The cellular context makes the difference. Prog. Neurobiol. 78 (2006) 364-373
15. Tanzi R.E., and Bertram L. Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective. Cell 120 (2005) 545-555
16. Sparks D.L., and Schreurs B.G. Trace amounts of copper in water induced β-amyloid plaques and learning deficits in a rabbit model of Alzheimer's disease. Proc. Natl. Acad. Sci. USA 100 (2003) 11065-11069
17. Jhoo J.H., Kim H.C., Nabeshima T., Yamadad K., Shin E.J., Jhoo W.K., Kim W., Kange K.S., Jo S.A., and Woo J.I. β-Amyloid(1-42)-induced learning and memory deficits in mice: involvement of oxidative burdens in the hippocampus and cerebral cortex. Behav. Brain Res. 155 (2004) 185-196
18. Pappolla M.A., Smith M.A., Bryant-Thomas T., Bazan N., Petanceska S., Perry G., Thal L.J., Sano M., and Refolo L.M. Cholesterol, oxidative stress, and Alzheimer's disease: expanding the horizons of pathogenesis. Free Radic. Bio. Med. 33 (2002) 173-181
19. Subramaniam R., Koppal T., Green M., Yatin S., Jordan B., Drake J., and Butterfield D.A. The free radical antioxidant Vitamin E protects cortical synaptosomal membranes from amyloid beta-peptide (25-35) toxicity but not from hydroxynonenal toxicity: relevance to the free radical hypothesis of Alzheimer's disease. Neurochem. Res. 23 (1998) 1403-1410
20. Lu J., Zheng Y.L., Luo L., Wu D.M., Sun D.S., and Feng Y.J. Quercetin reverses d-galactose induced neurotoxicity in mouse brain. Behav. Brain Res. 171 (2006) 251-260
21. Uchiyama M., and Mihara M. Determination of malondialdehyde precursor in tissue by thiobarbituric acid test. Anal. Biochem. 86 (1978) 271-278
22. Formentin E., Varotto S., Costa A., Downey P., Bregante M., Naso A., Picco C., Gambale F., and Lo Schiavo F. DKT1, a novel K+ channel from carrot, forms functional heteromeric channels with KDC1. FEBS Lett. 573 (2004) 61-67
23. Smart E.J., Ying Y.S., Conrad P.A., and Anderson R.G.W. Caveolin moves from caveolae to the Golgi apparatus in response to cholesterol oxidation. J. Cell. Biol. 127 (1994) 1185-1197
24. Murata M., Peranen J., Schreiner R., Weilan F., Kurzchalia T., and Simons K. VIP21/Caveolin is a cholesterol-binding protein. Proc. Natl. Acad. Sci. USA 92 (1995) 10339-10343
25. Pfrieger F.W. Role of cholesterol in synapse formation and function. BBA-Biomembranes 1610 (2003) 271-280
26. Wolozin B., Kellman W., Ruosseau P., Celesia G.G., and Siegel G. Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme a reductase inhibitors. Arch. Neurol. 57 (2000) 1439-1443
27. Maiese K. Organic brain disease. In: Ramachandran V.S. (Ed). Encyclopedia of the Human Brain. first ed. (2002), Academic Press, San Diego, CA 509-527
28. White A.R., Multhaup G., Maher F., Bellingham S., Camakaris J., Zheng H., Bush A.I., Beyreuther K., Masters C.L., and Cappai R. The Alzheimer's disease amyloid precursor protein modulates copper-induced toxicity and oxidative stress in primary neuronal cultures. J. Neurosci. 19 (1999) 9170-9179
29. Lovell M.A., Robertson J.D., Teesdale W.J., Campbell J.L., and Markesbery W.R. Copper, iron and zinc in Alzheimer's disease senile plaques. J. Neurol. Sci. 158 (1998) 47-52
30. Gervais F.G., Xu D., Robertson G.S., Vaillancourt J.P., Zhu Y., Huang J., LeBlanc A., Smith D., Rigby M., Shearman M.S., Clarke E.E., Zheng H., Van Der Ploeg L.H.T., Ruffolo S.C., Thornberry N.A., Xanthoudakis S., Zamboni R.J., Roy S., and Nicholson D.W. Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-beta precursor protein and amyloidogenic A-beta peptide formation. Cell 97 (1999) 395-406